ARCHIVES

Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

To Industry for Development, NDA

November 18, 1977

Two Phase III Afatinib Trials Demonstrate Prolonged Survival

May 30, 2014

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011

Stovall To Step Down As NCCS President At End Of 2008.

September 21, 2007

M.D. Anderson Wins Nearly $54 Million in ARRA Funding From NIH

November 6, 2009

NCI Will Encourage More Nutrition Research, Upton Tells McGovern

June 23, 1978